City
Epaper

Scientist who worked at Wuhan lab makes startling revelation; says COVID was man-made virus

By ANI | Updated: December 5, 2022 18:30 IST

In what appears to be an astonishing revelation, a US-based scientist, who worked at a controversial research lab in ...

Open in App

In what appears to be an astonishing revelation, a US-based scientist, who worked at a controversial research lab in China's Wuhan, has said that COVID-19 was a "man-made virus" that leaked from the facility.

COVID was leaked from Wuhan Institute of Virology (WIV), a state-run and funded research facility, two years ago, the New York Post reported, quoting US-based researcher Andrew Huff's statement in the British newspaper The Sun.

In his latest book, "The Truth About Wuhan," epidemiologist Huff claims that the pandemic was caused by the US government's funding of coronaviruses in China. Excerpts of Huff's book have been out in the UK-based tabloid The Sun.

According to the New York Post report, Huff is the former vice president of the EcoHealth Alliance, a non-profit organisation based in New York that studies infectious diseases.

Huff claims in his book that China's gain-of-function experiments were conducted with inadequate security, resulting in a leak at the Wuhan lab, according to New York Post.

The Wuhan lab has been the centre of heated debates over the origins of COVID, with both Chinese government officials and lab workers denying that the virus originated there.

"Foreign laboratories did not have the adequate control measures in place for ensuring proper biosafety, biosecurity, and risk management, ultimately resulting in the lab leak at the Wuhan Institute of Virology," Andrew Huff, said in his book.

For more than a decade, the organisation has been studying several coronaviruses in bats with funding from the National Institutes of Health (NIH) and has forged close ties to the Wuhan lab.The NIH is the primary agency of the United States government responsible for biomedical and public health research.

Huff, who worked at EcoHealth Alliance from 2014 to 2016, stated that the non-profit assisted the Wuhan lab for many years in developing the "best existing methods to engineer bat coronaviruses to attack other species"

"China knew from day one that this was a genetically engineered agent," Huff wrote. "The US government is to blame for the transfer of dangerous biotechnology to the Chinese. "I was terrified by what I saw," he told The Sun, as per New York Post. "We were just handing them bioweapon technology."

The Post also reports that according to a recent investigation published by ProPublica/Vanity Fair, the WIV is home to China's riskiest coronavirus research.

This research institute has been under immense pressure from the ruling Chinese Communist Party to produce scientific breakthroughs to raise its global status despite the lack of resources.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Andrew huffchinaWuhanNew York PostWuhan institute of virologyWuhan instituteThe new york post
Open in App

Related Stories

International'Illegal Military Operations': China Accuses US and Israel of Strait of Hormuz Crisis

NationalDelhi Government Orders Removal of 2.5 Lakh Chinese CCTV Cameras Over Security Concerns

InternationalChina: Four Dead, Nine Injured After Explosion at Highway Tunnel Construction Site in Chongqing

InternationalChina: Casualties Feared After Bulldozer Runs Over Crowd in Beijing Market (Watch Video)

MumbaiMumbai: DRI Seizes Restricted Goods Worth ₹9.25 Crore; Two Firm Owners Arrested

Health Realted Stories

HealthMeditation can help find solutions to global challenges: V-P Radhakrishnan

HealthIndia’s pharmaceutical exports exceed $28 billion up to February

HealthGujarat: Hotels, eateries fined for paneer display violations; 615 kg of substandard food destroyed

HealthMinistry of Social Justice clocks highest-ever Rs 11,810 crore expenditure in FY26

HealthIndia to boost biosimilar insulin, CGM manufacturing as Global South looks for support